Related Experiment Video

Updated: Jun 23, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 18, 2014

Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study

P Saikku1, M Leinonen, L Tenkanen

  • 1University of Helsinki, Finland.

Annals of Internal Medicine
|February 15, 1992
PubMed

Insights

Chronic Chlamydia pneumoniae infection, indicated by antibodies or immune complexes, is a significant risk factor for coronary heart disease. This study highlights the link between this infection and cardiovascular events.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Coronary heart disease (CHD) is a leading cause of mortality worldwide.
  • The role of chronic infections as a potential risk factor for CHD is an area of ongoing research.
  • Chlamydia pneumoniae is a bacterium implicated in respiratory infections and has been investigated for its potential link to cardiovascular diseases.

Purpose of the Study:

  • To investigate whether chronic Chlamydia pneumoniae infection is a risk factor for the development of coronary heart disease.
  • To assess the association between elevated antibody titers against C. pneumoniae, chlamydial lipopolysaccharide-containing immune complexes, or both, and the risk of CHD.

Main Methods:

  • Prospective Helsinki Heart Study, a randomized, double-blind, placebo-controlled trial.
  • Serum samples from CHD case patients and matched controls were analyzed for markers of chronic chlamydial infection.
  • Measurements included immunoglobulin A (IgA) and G (IgG) antibodies to C. pneumoniae and lipopolysaccharide-containing immune complexes.

Main Results:

  • Elevated IgA titers to C. pneumoniae were associated with an odds ratio (OR) of 2.7 for CHD.
  • The presence of immune complexes showed an OR of 2.1 for CHD.
  • Having both elevated IgA titers and immune complexes indicated an OR of 2.9 for CHD, even after adjusting for traditional risk factors.

Conclusions:

  • The findings suggest that chronic Chlamydia pneumoniae infection is a significant risk factor for coronary heart disease.
  • The presence of specific antibodies and immune complexes related to C. pneumoniae may indicate an increased susceptibility to cardiovascular events.
  • Further research is warranted to elucidate the mechanisms underlying this association and its clinical implications.
Abstract

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...